Yes sir, I did. Seems most are in this for a buyout and expect that to happen much before any drug approval. Since I didn't spend the time reading back very far on posts, I did not know if my question was redundant or not. You can post your number, as it is safe with me.
What I don't get that if this is an indeed a great target for buy out why wouldn't the buyer make the move now when it is as these ridiculously reduced prices? What factors will change that would make this stock a better or worse buyout option in the next few years?